Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression

Katharina Hochheiser, Christoph Heuser, Torsten Krause, Simon A. Teteris, Anissa Ilias(Délégation Paris 5), Christina Weisheit(University of Bonn), Florian Hoß, André P. Tittel, Percy A. Knolle(Technical University of Munich), Ulf Panzer(Universität Hamburg), Daniel R. Engel, Pierre‐Louis Tharaux(Délégation Paris 5), Christian Kurts
Journal of Clinical Investigation
September 2, 2013
Cited by 93Open Access
Full Text

Abstract

DCs and macrophages both express the chemokine receptor CX3CR1. Here we demonstrate that its ligand, CX3CL1, is highly expressed in the murine kidney and intestine. CX3CR1 deficiency markedly reduced DC numbers in the healthy and inflamed kidney cortex, and to a lesser degree in the kidney medulla and intestine, but not in other organs. CX3CR1 also promoted influx of DC precursors in crescentic glomerulonephritis, a DC-dependent aggressive type of nephritis. Disease severity was strongly attenuated in CX3CR1-deficient mice. Primarily CX3CR1-dependent DCs in the kidney cortex processed antigen for the intrarenal stimulation of T helper cells, a function important for glomerulonephritis progression. In contrast, medullary DCs played a specialized role in inducing innate immunity against bacterial pyelonephritis by recruiting neutrophils through rapid chemokine production. CX3CR1 deficiency had little effect on the immune defense against pyelonephritis, as medullary DCs were less CX3CR1 dependent than cortical DCs and because recruited neutrophils produced chemokines to compensate for the DC paucity. These findings demonstrate that cortical and medullary DCs play specialized roles in their respective kidney compartments. We identify CX3CR1 as a potential therapeutic target in glomerulonephritis that may involve fewer adverse side effects, such as impaired anti-infectious defense or compromised DC functions in other organs.


Related Papers

No related papers found

Powered by citation graph analysis